Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 126, Issue 12, Pages 4497-4515Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI86359
Keywords
-
Categories
Funding
- Marie Curie International Outgoing Fellowship for Career Development: European Union's Seventh Framework Programme (FP7-PEOPLE-IOF) [299954]
- Charge de recherches fellowship of the Belgian National Fund for Scientific Research (F.R.S.-FNRS)
- Acteria Foundation
- French Fondation pour la Recherche Medicale (FRM) [SPE20130326582]
- Philippe Foundation
- Max Kade Fellowship of the Max Kade Foundation
- Austrian Academy of Sciences
- Schroedinger Fellowship of the Austrian Science Fund (FWF) [J3399-B21]
- Arthritis National Research Foundation
- NIH [K99AI110645, AI023990, CA072074, AI070813, AR067145]
- F.R.S.-FNRS
- Department of Pathology, Stanford University School of Medicine
Ask authors/readers for more resources
Epidermal keratinocytes form a structural and immune barrier that is essential for skin homeostasis. However, the mechanisms that regulate epidermal barrier function are incompletely understood. Here we have found that keratinocyte-specific deletion of the gene encoding RAB guanine nucleotide exchange factor 1 (RABGEF1, also known as RABEX-5) severely impairs epidermal barrier function in mice and induces an allergic cutaneous and systemic phenotype. RABGEF1-deficient keratinocytes exhibited aberrant activation of the intrinsic IL-1R/MYD88/NF-kappa B signaling pathway and MYD88-dependent abnormalities in expression of structural proteins that contribute to skin barrier function. Moreover, ablation of MYD88 signaling in RABGEF1-deficient keratinocytes or deletion of Il1r1 restored skin homeostasis and prevented development of skin inflammation. We further demonstrated that epidermal RABGEF1 expression is reduced in skin lesions of humans diagnosed with either atopic dermatitis or allergic contact dermatitis as well as in an inducible mouse model of allergic dermatitis. Our findings reveal a key role for RABGEF1 in dampening keratinocyte-intrinsic MYD88 signaling and sustaining epidermal barrier function in mice, and suggest that dysregulation of RABGEF1 expression may contribute to epidermal barrier dysfunction in allergic skin disorders in mice and humans. Thus, RABGEF1-mediated regulation of IL-1R/MYD88 signaling might represent a potential therapeutic target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available